QuickView for tcpobop (compound)

1. Liver of CAR KO and KO with human CAR rescue treated with different ligands
2. Primary hepatocytes treated with non-genotoxic carcinogens or non-carcinogens
3. Embryonic stem cells treated with non-genotoxic carcinogens or non-carcinogens
4. Liver from mice treated with PXR or CAR ligands
5. Livers of CYP2B9/10/13 knockout mice treated with TCPOBOP

1. Off-target lipid metabolism disruption by the mouse constitutive androstane receptor ligand TCPOBOP …
2. Impact of CAR Agonist Ligand TCPOBOP on Mouse Liver Chromatin Accessibility.
3. Global analysis of expression, maturation and subcellular localization of mouse liver transcriptome …
4. Identification of Candidate Target Cyp Genes for microRNAs Whose Expression Is Altered by PCN and TC…
5. Impact of Neonatal Activation of Nuclear Receptor CAR (Nr1i3) on Cyp2 Gene Expression in Adult Mouse…

There were no clinical trials for tcpobop